Science China Life Sciences

, Volume 56, Issue 11, pp 1014–1019 | Cite as

Frequency of HLA-A*03 associates with HIV-1 infection in a Chinese cohort

  • WeiLun Zhang
  • Li Wang
  • KunXue Hong
  • YanXin Liu
  • Bing Su
  • Cheng Xu
  • JianQin Xu
  • YuHua Ruan
  • YiMin Shao
  • DeXian Zheng
Open Access
Research Paper


During the early mid-1990s, a number of rural farmers across central China were employed to the unregulated plasmaselling-activity and many of them were infected by HIV-1. However, AIDS progression in the former blood donors (FBDs) is various. The aim of this study is to assess human leukocyte antigen (HLA) class I allele distribution in FBDs and evaluate its association with HIV-1 infection and disease progression. A total of 353 FBDs were enrolled in the cohort including 294 ART naïve HIV-1 seropositive and 59 HIV-1 seronegative age-matched subjects. The viral load and CD4/CD8 T cell counts were assessed in all subjects. Compared with HIV-seropositive group, the frequency of HLA-A*03 in control was significantly higher. After classifying the HLA-B alleles of the subjects according to the presence of Bw4/Bw6 serological epitopes, detrimental effect of HLA Bw6/ Bw6 homozygosity was also confirmed in the HIV-seropositive subjects. This study provides novel evidence on HLA class I allele distribution and association of HLA-A*03 frequency with HIV-1 infection and viremia in the HIV-1 infected FBDs, which may throw light on intervention strategy for the HIV-1 infection and our understanding how host immunity and genetic background affect HIV infection and AIDS progression.


leukocyte antigen class I HIV-1 infection viremia control Chinese former blood donor cohort 


  1. 1.
    Bacchetti P, Moss A R. Incubation period of AIDS in San Francisco. Nature, 1998, 338: 251–253CrossRefGoogle Scholar
  2. 2.
    Hessol N A, Koblin B A, van Griensven G J, et al. Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978–1991. Am J Epidemiol, 1994, 139: 1077–1087PubMedGoogle Scholar
  3. 3.
    Muñoz A, Wang M C, Bass S, et al. Acquired immunodeficiency syndrome (AIDS)-free time after human immunodeficiency virus type 1 (HIV-1) seroconversion in homosexual men. Am J Epidemiol, 1989, 130: 530–539PubMedGoogle Scholar
  4. 4.
    Hendriks J C, Medley G F, van Griensven G J, et al. The treatment-free incubation period of AIDS in a cohort of homosexual men. AIDS, 1993, 7: 231–239PubMedCrossRefGoogle Scholar
  5. 5.
    Haynes B F, Pantaleo G, Fauci A S. Toward an understanding of the correlates of protective immunity to HIV infection. Science, 1996, 271: 324–328PubMedCrossRefGoogle Scholar
  6. 6.
    Baker E, Machewicz C E, Reyes-Teran G, et al. Virological and immunological features of long-term human immunodeficiency virus-infected individuals who have remained asymptomatic compared with those who have progressed to acquired immunodeficiency syndrome. Blood, 1998, 92: 3105–3114Google Scholar
  7. 7.
    Deeks S G, Walker B D. Human immunodeficiency virus controllers: Mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity, 2007, 27: 406–416PubMedCrossRefGoogle Scholar
  8. 8.
    Walker B D. Elite control of HIV Infection: implications for vaccines and treatment. Top HIV Med, 2007, 15: 134–136PubMedGoogle Scholar
  9. 9.
    Gray R H, Wawer M J, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet, 2001, 357: 1149–1153PubMedCrossRefGoogle Scholar
  10. 10.
    Darby S C, Ewart D W, Giangrande P L, et al. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet, 1996, 347: 1573–1579PubMedCrossRefGoogle Scholar
  11. 11.
    Operskalski E A, Stram D O, Lee H, et al. Human immunodeficiency virus type 1 infection: Relationship of risk group and age to rate of progression to AIDS. J Infect Dis, 1995, 172: 648–655PubMedCrossRefGoogle Scholar
  12. 12.
    Farzadegan H, Hoover D R, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet, 1998, 352: 1510–1514PubMedCrossRefGoogle Scholar
  13. 13.
    Sterling T R, Vlahov D, Astemborski J, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med, 2001, 344: 720–725PubMedCrossRefGoogle Scholar
  14. 14.
    Carrington M, O’Brien S J. The influence of HLA genotype on AIDS. Annu Rev Med, 2003, 54: 535–551PubMedCrossRefGoogle Scholar
  15. 15.
    Roger M. Influence of host genes on HIV-1 disease progression. FASEB J, 1998, 12: 625–632PubMedGoogle Scholar
  16. 16.
    Meier U C, Owen R E, Taylor E, et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol, 2005, 79: 12365–12374PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Fauci A S, Mavilio D, Kottilil S. NK cells in HIV infection: Paradigm for protection or targets for ambush. Nat Rev Immunol, 2005, 5: 835–844PubMedCrossRefGoogle Scholar
  18. 18.
    Mavillio D, Benjamin J, Daucher M, et al. Natural killer cells in HIV-1 infection: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci USA, 2003, 100: 15011–15016CrossRefGoogle Scholar
  19. 19.
    Wang S H, Xing H, Wang J J, et al. Sequence analysis of gag and env genes of HIV type 1 circulating in former blood donors of Fuyang city, Anhui province. Natl Med J China, 2007, 87: 1535–1539Google Scholar
  20. 20.
    Lewis C M. Genetic association studies: Design, analysis and interpretation. Brief Bioinform, 2002, 3: 146–153PubMedCrossRefGoogle Scholar
  21. 21.
    Xu C, Chen Q W, Ding X P. On HIV scanning and infectious condition of former blood donors in Fuyang city. Chin Rural Health Service Admin, 2006, 26: 44–46Google Scholar
  22. 22.
    Zhai S, Zhuang Y, Song Y, et al. HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China. Curr HIV Res, 2008, 6: 335–350PubMedCrossRefGoogle Scholar
  23. 23.
    Gao X, Nelson G W, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med, 2001, 344: 1668–1675PubMedCrossRefGoogle Scholar
  24. 24.
    Li S, Jiao H, Yu X, et al. Human leukocyte antigen class I and class II allele frequencies and HIV-1 infection associations in a Chinese cohort. J Acquir Immue Defic Syndr, 2007, 44: 121–131CrossRefGoogle Scholar
  25. 25.
    Racape J, Connan F, Hoebeke J, et al. Influence of dominant HIV-1 epitopes on HLA-A3/peptide complex formation. Proc Natl Acad Sci USA, 2006, 103: 18208–18213PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Lichterfeld M, Williams K L, Mui S K, et al. T cell receptor crossrecognition of an HIV-1 CD8+ T cell epitope presented by closely related alleles from the HLA-A3 superfamily. Int Immunol, 2006, 18: 1179–1188PubMedCrossRefGoogle Scholar
  27. 27.
    Flores-Villanueva P O, Yunis E J, Delgado J C, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA, 2001, 98: 5140–5145PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Qing M, Li T, Han Y, et al. Accelerating effect of human leukocyte antigen-Bw6 homozygosity on disease progression in Chinese HIV-1-infected patients. J Acquir Immue Defic Syndr, 2006, 41: 137–139CrossRefGoogle Scholar

Copyright information

© The Author(s) 2013

Authors and Affiliations

  • WeiLun Zhang
    • 1
  • Li Wang
    • 1
  • KunXue Hong
    • 2
  • YanXin Liu
    • 1
  • Bing Su
    • 3
  • Cheng Xu
    • 4
  • JianQin Xu
    • 2
  • YuHua Ruan
    • 2
  • YiMin Shao
    • 2
  • DeXian Zheng
    • 1
  1. 1.Institute of Basic Medical SciencesChinese Academy of Medical Sciences & Peking Union Medical CollegeBeijingChina
  2. 2.State Key Laboratory for Infectious Disease Prevention and ControlNational Center for AIDS/STD Control and PreventionBeijingChina
  3. 3.Anhui Center for Disease Control and PreventionHefeiChina
  4. 4.Fuyang Center for Disease Control and PreventionFuyangChina

Personalised recommendations